FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103144922> ?p ?o ?g. }

• W2103144922 endingPage "75" @default.
• W2103144922 startingPage "2365" @default.
• W2103144922 abstract "Chemotherapy has shown little antitumor activity against advanced oral squamous cell carcinoma (OSCC) patients. Therefore, there is an urgent need to develop more effective therapeutic methods for patients with advanced OSCC. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor ligand family that selectively induces apoptosis of cancer cells. S-1 is a new oral antineoplastic agent that can induce apoptosis in various types of cancer cells, including OSCC. Hence, combined treatment of cancer cells with TRAIL and S-1 might exert dramatic antitumor effects on OSCC cells.In this study, the response of human OSCC cells to TRAIL alone and in combination with S-1 was examined using nude mouse xenograft models. S-1 (10 mg/kg/day, 5 times/week) was administered orally and TRAIL (1 mg/kg, 5 times/week) was injected into peritumoral tissue for three weeks. Apoptotic cells were detected by a TUNEL method. The protein expression of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), and orotate phosphoribosyl transferase (OPRT) were assessed using immunohistochemistry; their gene expression was determined using microdissection and RT-PCR, and their protein levels using ELISA.Combined therapy of TRAIL and S-1 exerted antitumor effects on human OSCC xenografts markedly and significantly induced apoptotic cells in tumors treated with TRAIL plus S-1. Immunohistochemistry showed that the expressions of TS and DPD were down-regulated, and that OPRT expression was up-regulated in tumors treated with TRAIL plus S-1. In the same way, microdissection and RT-PCR revealed that the expression of TS and DPD mRNA was down-regulated and that expression of OPRT mRNA was up-regulated in tumors administered the combined treatment. Moreover, ELISA indicated that the protein levels of TS and DPD were down-regulated, and that OPRT was up-regulated in tumors treated with the combined therapy. During the experimental period, no loss of body weight was observed in mice treated with the combined therapy.These findings demonstrate that the combination of TRAIL and S-1 is effective against OSCC and has the potential of being a new therapeutic tool for future treatment of these tumors." @default.
• W2103144922 created "2016-06-24" @default.
• W2103144922 creator A5017283819 @default.
• W2103144922 creator A5029612923 @default.
• W2103144922 creator A5044297659 @default.
• W2103144922 creator A5062817518 @default.
• W2103144922 date "2007-08-19" @default.
• W2103144922 modified "2023-10-16" @default.
• W2103144922 title "Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice." @default.
• W2103144922 cites W1484817497 @default.
• W2103144922 cites W1499419719 @default.
• W2103144922 cites W1512459177 @default.
• W2103144922 cites W1560001018 @default.
• W2103144922 cites W1675957369 @default.
• W2103144922 cites W191332462 @default.
• W2103144922 cites W1974449546 @default.
• W2103144922 cites W2001709842 @default.
• W2103144922 cites W2005627135 @default.
• W2103144922 cites W2016378932 @default.
• W2103144922 cites W2018619890 @default.
• W2103144922 cites W2025128734 @default.
• W2103144922 cites W2029463606 @default.
• W2103144922 cites W2031866781 @default.
• W2103144922 cites W2035456243 @default.
• W2103144922 cites W2056217426 @default.
• W2103144922 cites W2075279309 @default.
• W2103144922 cites W2077902459 @default.
• W2103144922 cites W2086268492 @default.
• W2103144922 cites W2089684638 @default.
• W2103144922 cites W2090941375 @default.
• W2103144922 cites W2106284224 @default.
• W2103144922 cites W2109232632 @default.
• W2103144922 cites W2116846790 @default.
• W2103144922 cites W2126018463 @default.
• W2103144922 cites W2126959399 @default.
• W2103144922 cites W2130988210 @default.
• W2103144922 cites W2131926022 @default.
• W2103144922 cites W2134812217 @default.
• W2103144922 cites W2136509693 @default.
• W2103144922 cites W2154563532 @default.
• W2103144922 cites W61003746 @default.
• W2103144922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17695527" @default.
• W2103144922 hasPublicationYear "2007" @default.
• W2103144922 type Work @default.
• W2103144922 sameAs 2103144922 @default.
• W2103144922 citedByCount "3" @default.
• W2103144922 countsByYear W21031449222017 @default.
• W2103144922 crossrefType "journal-article" @default.
• W2103144922 hasAuthorship W2103144922A5017283819 @default.
• W2103144922 hasAuthorship W2103144922A5029612923 @default.
• W2103144922 hasAuthorship W2103144922A5044297659 @default.
• W2103144922 hasAuthorship W2103144922A5062817518 @default.
• W2103144922 hasConcept C104317684 @default.
• W2103144922 hasConcept C11242284 @default.
• W2103144922 hasConcept C121608353 @default.
• W2103144922 hasConcept C123321153 @default.
• W2103144922 hasConcept C126322002 @default.
• W2103144922 hasConcept C142724271 @default.
• W2103144922 hasConcept C17991360 @default.
• W2103144922 hasConcept C190283241 @default.
• W2103144922 hasConcept C204232928 @default.
• W2103144922 hasConcept C2780456651 @default.
• W2103144922 hasConcept C502942594 @default.
• W2103144922 hasConcept C55493867 @default.
• W2103144922 hasConcept C71924100 @default.
• W2103144922 hasConcept C86803240 @default.
• W2103144922 hasConcept C96232424 @default.
• W2103144922 hasConceptScore W2103144922C104317684 @default.
• W2103144922 hasConceptScore W2103144922C11242284 @default.
• W2103144922 hasConceptScore W2103144922C121608353 @default.
• W2103144922 hasConceptScore W2103144922C123321153 @default.
• W2103144922 hasConceptScore W2103144922C126322002 @default.
• W2103144922 hasConceptScore W2103144922C142724271 @default.
• W2103144922 hasConceptScore W2103144922C17991360 @default.
• W2103144922 hasConceptScore W2103144922C190283241 @default.
• W2103144922 hasConceptScore W2103144922C204232928 @default.
• W2103144922 hasConceptScore W2103144922C2780456651 @default.
• W2103144922 hasConceptScore W2103144922C502942594 @default.
• W2103144922 hasConceptScore W2103144922C55493867 @default.
• W2103144922 hasConceptScore W2103144922C71924100 @default.
• W2103144922 hasConceptScore W2103144922C86803240 @default.
• W2103144922 hasConceptScore W2103144922C96232424 @default.
• W2103144922 hasIssue "4B" @default.
• W2103144922 hasLocation W21031449221 @default.
• W2103144922 hasOpenAccess W2103144922 @default.
• W2103144922 hasPrimaryLocation W21031449221 @default.
• W2103144922 hasRelatedWork W2006724080 @default.
• W2103144922 hasRelatedWork W2023082526 @default.
• W2103144922 hasRelatedWork W2028644537 @default.
• W2103144922 hasRelatedWork W2034366718 @default.
• W2103144922 hasRelatedWork W2350468705 @default.
• W2103144922 hasRelatedWork W2378235736 @default.
• W2103144922 hasRelatedWork W2790875452 @default.
• W2103144922 hasRelatedWork W2979122220 @default.
• W2103144922 hasRelatedWork W3030327680 @default.
• W2103144922 hasRelatedWork W3140303761 @default.
• W2103144922 hasVolume "27" @default.
• W2103144922 isParatext "false" @default.

• next